The scenario of the Pediatric Vaccines segment : Ken Research

India has emerged as the leading vaccine producer in the world, in terms of doses of vaccines produced, and has about ~ major vaccine manufacturing facilities across the country. Vaccines manufactured in these facilities are offered in both national and international market (over 150 countries). With over ~ million births every year, the domestic market for vaccines in India is huge. The country has been self sufficient in meeting the domestic needs, with private sector responsible for providing a large part of the supply needs. However, India lacks in coverage rate of basic vaccines.
The Indian domestic market for Universal Immunization Programme (UIP) alone is over ~ million doses. The R&D cost of UIP vaccines is minimal; however, the non-UIP vaccines involve technology licensing, R&D, infrastructure and operational costs. In addition, stringent regulatory requirements for the licensing of newer vaccines, add up to the cost.

More than ~% of all measles vaccines used globally are produced in India. Moreover, Indian firms are big suppliers to the UN agencies, accounting in between ~% and ~% of the vaccines purchased by organization every year. India has emerged as a major vaccine producer in recent times by focusing on geographical regions where vaccines are not funded by the UN or charitable organizations and strategic ties with UN and government agencies to supply vaccines at affordable prices.
The Indian pediatric market for vaccines has grown at a remarkable CAGR of ~% during the period FY’2011-FY’2016.
The growth was attributed to some crucial vaccines (polio, hepatitis B, MMR and BCG) manufactured by Indian companies constantly featured in WHO’s prequalified list coupled with the fact that Indian companies (Serum Institute of India, Bharat Biotech, Panacea Biotec) acted as major suppliers of vaccines to WHO, UNICEF, PATH and other UN agencies. The market for pediatric vaccines grew from INR ~ billion in FY’2011 to INR ~ billion in FY’2016.
Monovalent vaccines are meant to immunize against a single antigen or a single microorganism. A fact that large chunk of vaccines administered under the national immunization programme in the country are of the monovalent form, is the major factor which has resulted in high revenue contribution from the segment. This includes monovalent oral polio vaccine, BCG, measles, Hepatitis B and Hib. Some other commonly used monovalent vaccines include rotavirus vaccine and TT.
Topics Covered in the Report

• Vaccines Market Growth India,
• Drug Pipeline Pediatric ,
• Pediatric tuberculosis drug Market,
• Number of Pediatrician  Statistics,
• Drug Information Dosage Side Effects,
• Pediatric Vaccine Serum Institute of India,
• New Drug Launches India Pharma Sector,

For more information about the publication, refer to below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/india-pediatric-drug-vaccine-market/81319-91.html
Related Reports:
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market
US Aesthetic Lasers and Energy Devices Market Outlook to 2020 - Aging Population and High Prevalence Rate of Obesity to Foster Future Growth
Qatar Wellness Market Outlook to 2020 - Rising Awareness about health & Fitness and Prevalence in Lifestyle Diseases will drive the Market
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Cervical Cancer Screening Market & Patients-North America: Ken Research

Ken research announced recent publication on, "Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America". This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases. It provides a comprehensive analysis and forecast till 2020. This report provides a complete analysis of 2 Countries Cervical Cancer Test Market & Number of Cervical Cancer Population. Studied countries in the report have been studied from 3 viewpoints.

• Cervical cancer Test Population (2008-2020) Pap smear test population (HPV DNA test population 2008-2020)
• Cervical Cancer Mortality Population (2001-2011)
• Cervical Cancer Test Market (2008-2020)

The Pap test finds changes in the cells of the cervix (the mouth of the womb) that are not normal. When a female has a Pap test, she is positioned on an exam table and a device called a speculum is gently inserted to open the vagina. The speculum allows the healthcare provider to view the cervix and upper vagina. Once the provider can see the cervix, a “broom” device or a brush/spatula combination will be used to collect the cells. Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated that over 4,000 women in the United States and 400 women in Canada die from cervical cancer in 2016. However, it is also one of the most preventable types of cancer. Pap smear and HPV DNA test are two most popular testing methods to diagnose cervical cancer cases in North America. United States is the leader in North America cervical cancer test market. It holds over 90 percent testing population share alone, and is likely to maintain its position in forecasting period as well due to women getting regular Pap tests. The main risk factor for developing cervical cancer is the sexually transmitted human papilloma virus (HPV) that infects the cervix.

Other risk factors for developing cervical cancer include:

Becoming sexually active at a young age; having many sexual partners, or having a sexual partner that has had many sexual partners.

Smoking.

An immune system weakened from taking drugs following a transplant, or having a disease such as AIDS.

The use of birth control pills for a long period of time.

Giving birth to many children.

Having taken diethylstilbestrol (DES), or being the daughter of a mother who took DES.

Market Segmentation

This research report categorizes the global cervical cancer screening market on the basis of type of test, and end users.

Cervical Cancer Screening Market, by Test

• Pap tests
• HPV test/ Co-testing

Cervical Cancer Screening Market, y End User

• Hospitals
• Laboratories
• Physician’s offices and clinics

Cervical Cancer Screening Market, by Geography

• North America
• Europe
• Asia-Pacific
• RoW (Rest of the World)

Testing market is estimated to reach USD 8.5 Billion in 2020, expanding at a CAGR of 5.5% from 2016 to 2020, due to higher incidence of human papilloma virus (HPV) infections worldwide. Pap smear tests and colposcopy contributed to the largest share of the global cervical cancer diagnostic testing market, while HPV typing segment registered highest growth rate. By geography, North America dominated the overall market growth followed by Europe, while Asia Pacific region registered higher growth rate and likely continue to the same during the forecast period from 2016-2020. Browse Cervical Cancer Diagnostic Testing Market by Test Type (Cervical Biopsy, Colposcopy, Endocervical Curettage, HPV Typing, Loop electrosurgical procedure, Pap Smear Testing), and Imaging Tests for Stage Detection (Computed tomography or CAT, Magnetic resonance imaging, Positron emission tomography, Chest X-Ray) Cervical cancer is one of the most common cancers in women worldwide. Cervical cancer occurs when abnormal cells on the cervix grow out of control.

A virus called human papillomavirus or HPV causes most cervical cancer. The virus spreads through sexual contact. It is a malignant tumor of the lower most part of the uterus (womb) that can be prevented by PAP smear screening and a HPV vaccine. Cervical cancer is the fourth-most common cause of cancer and the fourth-most common cause of deaths from cancer in women. Two major types of cervical cancers that are typically screened and diagnosed in women include adenocarcinoma and squamous cell carcinoma. The Pap test is a screening test, not a diagnostic test, while other tests include colposcopy (with biopsy), endocervical scraping, and cone biopsies. Imaging tests such as X-rays, CT scans, magnetic resonance imaging (MRI) and positron emission tomography (PET) help determine the spread of cancer.

PAP test is the largest segment of the global market. However, HPV/co-test will be the fastest-growing product segment during the forecast period. This report segments the global cervical cancer screening market by test, and end user. Based on type of test, the global market is segmented into PAP test, and HPV test/co-testing. Based on end users, the global cervical cancer diagnosis market is categorized into hospitals, laboratories, and physician’s offices and clinics. Laboratories segment is the major end users of the global market in 2014. 

Major players operating in the global cervical cancer diagnostic testing market and included in this report are Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., QIAGEN N.V., Femasys, Inc., Zilico Ltd., Guided Therapeutics, Inc., and OncoHealth Corp. Growth of this market is driven by growth in aging female population and rising prevalence rate of cervical cancer, high incidence rate of HPV infections, increasing number of awareness programs for cervical cancer diagnostic, and government initiatives and funding. Breakthrough products and technologies, and significant growth in the HPV test market provide new growth opportunities to players in the global market. However, Changes in regulatory guidelines for cervical cancer screening, and use of HPV vaccines are the key factors that are limiting growth of this market.  In addition, uncertain reimbursement scenario is the key market challenge.

Key Factors Considered in the Report

North America Cervical Cancer Market

North America Cervical Cancer Test Market And Forecast

North America Cervical Cancer Pap Smear Test Market

North America Cervical Cancer Hpv Dna Test Market

North America Cervical Cancer Test Market Share

North America Cervical Cancer Hpv Dna Test Market

United States Cervical Cancer Test Market

Us Cervical Cancer Pap Smear Test Future Outlook

Global Cervical Cancer Market Research

For more coverage click on the link below: 
https://www.kenresearch.com/healthcare/pharmaceuticals/canada-united-states-cervical-cancer/81992-91.html

 Related links:
https://www.kenresearch.com/healthcare/pharmaceuticals/japan-proton-therapy-market-forecast/81991-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/europe-cervical-cancer-test-market-patients/81990-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Presence of Foreign Insurers Uplifting Singapore Reinsurance Sector: Ken Research

Ken research announced its recent publication on "Reinsurance in Singapore, Key Trends and Opportunities to 2020" .The report provides a comprehensive analysis on the reinsurance market of Singapore. It  delineates about the competitive landscape in the country, gives a thorough overview of the Singaporean economy and demographic. It further provides detailed analysis of natural hazards and their impact on the Singaporean insurance industry.

The strength of this economy lies in its stable political and sound economic system. The nation is known for its excellent business environment and banking sector. Singapore has emerged as a high income country that is major trading regional and global hub for financial and trading services. Thus, this nation has become one of the very few nation ,which has current account surplus, ample foreign reserves and very low public external debt. However, on the other hand Singapore is highly dependent on exports, has a quite volatile.
Singapore has the most open insurance sector in the world and is fully open to foreign insurers. The MAS (monetary authority of Singapore) regulate the insurance market. This industry is currently in its boom phase as the investment and returns have been growing leaps and bounds. The introduction of FAIR ( Financial Advisory Industry Review) which has brought more transparency in production and sales . The MAS has also recommended  direct purchasing of the insurance product to combat rising operating cost and help to attract and retain talent. This move has drawn some flak from people citing that the nation is not ready for such a thing as yet but many insurance companies has supported this thought.    The insurers are licensed and  governed under the Insurance Act (Cap. 142) ("IA").Insurers can carry their business in Singapore as licensed insurers or foreign insurers. Licensed insurers can carry on direct life and/or general business, life and/or general reinsurance business or captive insurance. Foreign insurers operate in Singapore under a foreign insurer scheme established under Part IIA of the act  There are two foreign insurer designs- The Lloyd's Scheme and the Lloyd’s Asia Scheme.
Singapore is known as the reinsurance hub. Among the top 25 reinsurance companies in the world, 16 have their regional hub Singapore . with the increase in the natural catastrophes around the Asia- pacific region and Oceania, are forcing the insurance companies to share their revenues with the reinsurance companies. This has emerged as one the major reasons for the increase in the business in the reinsurance companies situated in Singapore. The multinational companies rule this market.
Authorized reinsurers and Approved Marine, Aviation and Transit ("MAT") insurers do not need to have a physical presence in Singapore. Such reinsurers can carry on the business of providing the reinsurance of liabilities under insurance policies in Singapore. They further may be authorised as general reinsurers and/or life reinsurers. MAT insurers do not write insurance business, other than the collection or receipt of premiums in relation to MAT insurance business.
Topics Covered in the Report

• Global insurance industry research
• Singapore Insurance Sector
• Singapore Life Insurance Market
• Singapore Non Life Insurance Market
• Singapore Re- Insurance Industry Future
• Singapore Reinsurance Industry Trends
• Singapore reinsurance Sector Regulations
• Singapore reinsurance gross Written Premium
• Global Reinsurance Industry
• Singapore Reinsurance Sector
• Reinsurance Market Research Singapore
• Singapore Reinsurance Sector Major players
• Singapore Reinsurance Industry size
• Singapore Reinsurance Industry growth
• Singapore Reinsurance Industry future
• Singapore Reinsurance Industry analysis

For more coverage click on the link below
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/reinsurance-singapore/74586-93.html
Related links
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/non-life-insurance-singapore/74584-93.html
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/personal-accident-health-insurance-singapore/74585-93.html
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/life-insurance-singapore/80113-93.html
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
queranalyseearch.com
+91-124-4230204
www.kenresearch.com

Stringent Regulations in the US Pharmaceutical and Medical Devices Market: Ken Research

Ken research announced recent publication on, "Country Focus: Healthcare, Regulatory and Reimbursement Landscape in US". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the US. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts. Profiles and SWOT analyses of the major players in the pharmaceutical market gives exceptional market view. The effective sales and marketing strategies can be understood by understanding the competitive landscape and analysing competitors' performance help gain competitive advantage. It is a very useful tool to organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

HEALTHCARE LANDSCAPE:

The population of the US in 2015 was 326 million, having grown at a CAGR of 1% from 2008. In 2015, the government spent 17.5% of GDP in 2015 on medical and health science and exported USD 32.8 billion of pharmaceutical products. These positive growth trends can be primarily attributed to

• Availability of latest drugs and technologies
• Universal health coverage
• Access to healthcare facilities

Major players in the medical device market include Johnson and Johnson, GE Healthcare, Siemens, Medtronic, and Philips Healthcare. Health care in the United States is provided by many distinct organizations. Health care facilities are largely owned and operated by private sector businesses. 58% of US community hospitals are non-profit, 21% are government owned, and 21% are for-profit. According to the World Health Organization (WHO), the United States spent more on health care per capita, and more on health care as percentage of its GDP, than any other nation in 2011. Health spending was paid for by the government in 2013, funded via programs such as Medicare, Medicaid, the Children's Health Insurance Program, and the Veterans Health Administration. People aged under 67 acquire insurance via their or a family member's employer, by purchasing health insurance on their own, or are uninsured. Health insurance for public sector employees is primarily provided by the government In the U.S. Ownership of the health care system is mainly in private hands, though federal, state, county, and city governments also own certain facilities.

The non-profit hospitals share of total hospital capacity has remained relatively stable for decades. There are also privately owned for-profit hospitals as well as government hospitals in some locations, mainly owned by county and city governments. The Hill-Burton Act was passed in 1946, which provided federal funding for hospitals in exchange for treating poor patients.

REGULATORY AND LICENSING LANDSCAPE:

Healthcare is subject to extensive regulation at both the federal and the state level, much of which "arose haphazardly". Under this system, the federal government cedes primary responsibility to the states under the McCarran-Ferguson Act. Essential regulation includes the licensure of health care providers at the state level and the testing and approval of pharmaceuticals and medical devices by the U.S. Food and Drug Administration (FDA), and laboratory testing. These regulations are designed to protect consumers from ineffective or fraudulent healthcare. Additionally, states regulate the health insurance market and they often have laws which require that health insurance companies cover certain procedures although state mandates generally do not apply to the self-funded health care plans offered by large employers, which exempt from state laws under pre-emption clause of the Employee Retirement Income Security Act.

 In 2010, the Patient Protection and Affordable Care Act (PPACA) was passed by President Barack Obama and includes various new regulations, with one of the most notable being a health insurance mandate which requires all citizens to purchase health insurance. While not regulation per se, the federal government also has a major influence on the healthcare market through its payments to providers under Medicare and Medicaid, which in some cases are used as a reference point in the negotiations between medical providers and insurance companies. State governments maintain state health departments, and local governments (counties and municipalities) often have their own health departments, usually branches of the state health department. Regulations of a state board may have executive and police strength to enforce state health laws. In some states, all members of state boards must be health care professionals. Members of state boards may be assigned by the governor or elected by the state committee The McCarran–Ferguson Act, which cedes regulation to the states, does not itself regulate insurance, nor does it mandate that states regulate insurance. "Acts of Congress" that do not expressly purport to regulate the "business of insurance" will not preempt state laws or regulations that regulate the "business of insurance." The Act also provides that federal anti-trust laws will not apply to the "business of insurance" as long as the state regulates in that area, but federal anti-trust laws will apply in cases of boycott, coercion, and intimidation.

REIMBURSEMENT LANDSCAPE

The healthcare reimbursement system is an extremely multifaceted framework of obtaining payment for services. One of the most problematic issues is that the “rules” governing healthcare reimbursement change frequently, with government payers sometimes changing on a day-to-day basis. n addition, the price for the service is not the “retail” price that the provider charges for it. Payers have a “maximum allowed payment” for every CPT code, which is the beginning point (not the end point) of determining what they will pay. The payer then adjusts the maximum allowed payment with “claim edits,” which they use to disqualify payment for some services, and “payment rules,” which usually reduce payments for some services. The American Medical Association (AMA) describes how payments are affected by these two rules.

Key Factors Considered in the Report

US Healthcare Industry Research

US Pharmaceutical Industry Research

Pharmaceutical Market Revenue US

US Pharmaceutical Market Imports

Export Volume Of Pharmaceutical Products US

US Medical Devices Market Research

Healthcare IT Market Research US

US Cardiovascular Device Market Future Outlook

US Orthopedic Devices Market

For more coverage click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/countryfocus-healthcare-regulatory-us/80510-91.html

Related links:

https://www.kenresearch.com/healthcare/pharmaceuticals/canada-united-states-cervical-cancer/81992-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/japan-proton-therapy-market-forecast/81991-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Demand for data increases in Myanmar leads to expansion in 3G & 4G network : Ken Research

Ken Research announced the recent production on “Myanmar: 4G Investment and new market entrants to boost burgeoning telecoms market,” which offers insights on overview of the telecommunications market in Myanmar, with detailed forecasts of key indicators up to 2021. The production provides detailed analysis of the near-term opportunities, competitive dynamics and evolution of demand by service type and technology/platform across the fixed telephony, broadband, and mobile, as well as a review of key regulatory trends. Moreover, the report offers the shrewd investigation of the economic, demographic and political aspects in Myanmar along with it a review of the regulatory setting and agenda for the next 18-24 months as well as relevant developments pertaining to spectrum licensing, national broadband plans, number portability and more. In addition, the near-term opportunities for operators, vendors and investors in Myanmar's telecommunications markets are discussed.

Competition on the rise
Myanmar’s telecoms market remains relatively young; the novel incumbent nonetheless faces an increasingly competitive environment, with the two international service providers still striving to close the gap. The state-owned entity’s subscriber base has remained largely static since mid-2015, when it counted around 18m subscribers. Telenor, however, looks to be gaining ground, having added 1.9m customers to its base in the last three months of 2015. This brings its total to almost 14m, up from 3.4m at year-end 2014.
Mobile penetration reached 63% in early 2016, up from 54.6% in late March 2015, but still well below the levels found in many other markets in the region.
For their part, existing mobile operators have expressed fears that a new player could be given some competitive advantages, such as lower licence fees or more relaxed terms for the rollout of services – which could grant the new entrant a bigger slice of the more lucrative urban market.
Potential for growth
All the while, operators continued to invest in their networks in a bid to enhance coverage and services, with enhancements to data, in specific, being given priority.
In March, Ooredoo announced plans to spend $350m in 2016 on elevating download speeds and network reach, having channelled a similar level of capital into improving its operations last year. The eventual launch of 4G services should stimulate further expansion, with increased take-up of smartphones playing a pivotal role in heightening demand.
The major move, the government pledged in November to release the necessary spectrum once service providers are ready to launch their next-generation networks. This was followed by an announcement in February that the MCIT plans to hold auctions for additional spectrum to accommodate greater data usage.
Topics Covered in the Report

• Major telecommunications Industry Research,
• Myanmar telecom industry Developments,
• Major telecommunications Sector policy,
• Myanmar telecom Players Market Share,
• Myanmar smartphones penetration Market,
• Myanmar Fixed-line penetration Market,
• Myanmar telecommunications market Opportunities
• Myanmar telecommunications market size
• Myanmar telecommunications market trends
• Myanmar telecommunications marketn growth
• Myanmar telecommunications market share
• Myanmar telecommunications market future
• Myanmar telecommunications market analysis
• Myanmar telecommunications market research
• Myanmar telecommunications market

To know more on the coverage, tap on the link underneath:
https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/myanmar-4g-investment-new-market-entrants-boost/78616-105.html
Related Links
https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/philippines-mobile-data-digital-services-are-key-drivers/78617-105.html
https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/singapore-embracing-smart-nation-telco-media/78618-105.html
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
query@kenresearch.com
+91-124-4230204

Power of Hydropower in Australia: Ken Research

Ken research announced recent publication on, "Hydropower in Australia, Market Outlook to 2030, Update 2016-Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles”, the industry analysis specialists that offer comprehensive information and understanding of the hydropower market in Australia. The report provides in depth analysis on global renewable power market and global hydropower market with forecasts up to 2030. The report analyses the power market scenario in Australia (includes conventional thermal, nuclear, large hydro and renewable energy sources) and provides comprehensive viewpoint. The research details renewable power market outlook in the country (includes hydro, small hydro, biopower and solar PV). The report highlights installed capacity and power generation trends from 2006 to 2030, time. A detailed coverage of renewable energy policy framework governing the market with specific policies pertaining to hydropower is provided in the report. The research also provides company snapshots of some of the major market participants.

The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis of industry experts. A brief introduction on global carbon emissions and global primary energy consumption is given. Detailed overview of the global hydropower market with installed capacity and generation trends, installed capacity split by major hydropower countries in 2015 and key owners' information of various regions is provided. An overview on global renewable power market, highlighting installed capacity trends, generation trends and installed capacity split by various renewable power sources and the information is covered for the historical period 2006-2015 and forecast period 2015-2030. Position yourself to gain the maximum advantage of the industry's growth potential. It can be used to develop strategies based on the latest regulatory events and to identify key partners and business development avenues. It’s the key solution to understand and respond to your competitors' business structure, strategy and prospects.

Hydro uses flowing water to spin a turbine connected to a generator that produces electricity. The amount of electricity generated depends on the volume of water and the height of the water above the turbine. Hydropower is the most advanced and mature renewable energy technology and provides some level of electricity generation in more than 160 countries worldwide. Hydro is a renewable energy source and has the advantages of low greenhouse gas emissions, low operating costs, and a high ramp rate (quick response to electricity demand), enabling it to be used for either base or peak load electricity generation, or both.

Loy Yang in Victoria is the largest Power Station in Australia by capacity. Large hydroelectric power stations need dams to store the water required to produce electricity. These dams are often built to hold irrigation or drinking water, and the power station is included in the project to ensure maximum value is extracted from the water. Renewable power sources include wind (both onshore and offshore), solar photovoltaic (PV), concentrated solar power (CSP), small hydropower (SHP), biomass, biogas and geothermal. Hydropower currently accounts for about 40 per cent of the renewable electricity produced in Australia. Tasmania's hydroelectric plants and the Snowy River Hydro Scheme in New South Wales generate the majority of this energy.

Australia is the driest inhabited continent on earth, with over 80 per cent of its landmass receiving an annual average rainfall of less than 600 mm per year and 50 per cent less than 300 mm per year. There is also high variability in rainfall, evaporation rates and temperatures between years, resulting in Australia having very limited and variable surface water resources. Much of Australia's economically feasible hydro energy resource has already been harnessed. The amount of hydro power generated in 2015 was lower than 2014 due to low rainfall in key hydro catchments. Hydro Tasmania’s network endured the driest period on record between September and November, and storages dropped to a quarter of capacity (25.7 per cent). The majority of Australia's suitable hydro sites have already been developed, so the sector's opportunity for growth is limited. In coming years, most of the activity in the sector will be in developing mini hydro power plants or upgrading and refurbishing existing power stations

Australia has more than 100 operating hydroelectric power stations with total installed capacity of about 7800 megawatts (MW). These are located in the areas of highest rainfall and elevation and are mostly in New South Wales (55 per cent) and Tasmania (29 per cent). The Snowy Mountains Hydro-electric Scheme, with a capacity of 3800MW, is Australia's largest hydro scheme and is one of the most complex integrated water and hydroelectricity schemes in the world. The Scheme collects and stores the water that would normally flow east to the coast and diverts it through trans-mountain tunnels and power stations. The water is then released into the Murray and Murrumbidgee Rivers for irrigation. The Snowy Mountains Scheme comprises sixteen major dams, seven power stations (two of which are underground), a pumping station, 145km of inter-connected trans-mountain tunnels and 80km of aqueducts. The Snowy Mountains Hydro-electric Scheme accounts for around half of Australia's total hydroelectricity generation capacity and provides base load and peak load power to the eastern mainland grid of Australia.

Hydro energy is particularly important in Tasmania where it provides much of the state's electricity. The Tasmanian integrated hydropower scheme harnesses hydro energy from six major water catchments and involves 50 major dams, numerous lakes and 29 power stations with a total capacity of over 2600MW. The scheme provides base and peak load power to the National Electricity Market, firstly to Tasmania and then to the Australian network through Basslink, the undersea interconnector which runs under Bass Strait. There are also hydroelectricity schemes in north-east Victoria, Queensland, Western Australia, and a mini-hydroelectricity project in South Australia.

The levelised cost of electricity (LCOE) is a measure of a power source which attempts to compare different methods of electricity generation on a consistent basis. It is an economic assessment of the average total cost to build and operate a power-generating asset over its lifetime divided by the total energy output of the asset over that lifetime.  Shrinking rivers have already reduced or even shut down power generation in existing dams when their reservoirs dropped below critical levels. As a result, drought-stricken countries like Kenya, the Philippines, and Venezuela have suffered periodic blackouts and electricity rationing in recent years. The Australian hydro power industry has already attracted over one billion dollars of investment to further develop Australian hydro power projects. Opportunities for further growth in the hydro power industry are principally in developing mini hydro plants or refurbishing, upgrading and modernising Australia’s current fleet

Companies Covered

Snowy Hydro Limited, Origin Energy Limited, CS Energy Ltd, AGL Energy Limited

Key Factors Considered in the Report

Australia Hydropower Market

Hydropower Market Future Outlook Australia

Hydropower Generation Capacity Australia

Australia Energy Consumption

Global Renewable Power Installations

Thermal Power Market Australia

Global Carbon Emission

Australia Hydropower Market Investment Trends

Australia Renewable Energy Regulations

Australia  Renewable Energy Installed Capacity

For more coverage click on the link below:

https://www.kenresearch.com/energy-and-utilities/clean-technology/hydropower-australia-market-outlook/80511-103.html

Related links:

https://www.kenresearch.com/energy-and-utilities/clean-technology/bullfrog-power-inc-strategic/13924-103.html

https://www.kenresearch.com/energy-and-utilities/clean-technology/eaglepicher-technologies-llc-strategic/13944-103.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Expansion of 4G coverage in Philippines: Ken Research

Ken Research declared the recent distribution on “Philippines: Mobile data and digital services are key drivers of the telecom market,” which offers insightful knowledge on the telecommunications market in Philippines today, with detailed forecasts of key indicators up to 2021. The distribution provides detailed analysis of the near-term opportunities, competitive dynamics and evolution of demand by service type and technology/platform across the fixed telephony, broadband and mobile sectors, as well as a review of key regulatory trends.  Moreover, it offers in-depth analysis of telecom market size and trends in Philippines compared with other countries in the region, country’s Economic, demographic and political aspects, sector analysis of fixed telephony, broadband, mobile voice and mobile data, a quantitative analysis of service adoption trends by network technology and by operator, as well as of average revenue per line/subscription and service revenue through the end of the forecast period.

PDLT – dominant fixed line and mobile provider

Telecom sector in the Philippines has witnessed considerable investment and business activity since deregulation, the market has consistently fall short of its full potential. Despite, there certainly has been a lot of activity, with the market often finding a different direction from what was envisaged. Despite competition from novel carriers and mobile operators, PLDT has continued to be the Philippines’ major fixed-line and mobile provider and also has been a large part of the momentum in the country’s telecom market. Nevertheless, PLDT’s role has not gone untapped and lately Globe Telecom in particular has been pushing hard to overhaul the incumbent.

Mobile Penetration

The country’s mobile market has been specifically active for some years, for example, running on what could only be described as a genuine revolution in the development of SMS as an effective communications service. Even more significant ultimately has been the recent expansion in broadband. Broadband is finally building a healthy subscriber base, elevated by the considerable presence of mobile services in the mix of the various broadband platforms delivering internet access. There has also been good progress in the rollout of optical fibre infrastructure, although not on the national scale envisaged. In the meantime, the larger operators are building IP-based Next Generation Networks. Whilst the global financial problems presented some real challenges for the local telecom market, the negative impact seemed to have been put well behind now.

Major Developments

• PLDT introduced a quad-play service, bundling a mobile package with its voice, data and fibre services.
• Globe Telecoms successfully integrated its recently-acquired Bayan Telecommunications subsidiary into its operations.
• NTC approved a network sharing deal between Globe Telecom and ABS-CBN Corp;
• The deal was part of ABS-CBN Corp’s plan to become the country’s ‘third telecom player
• BellTel was making a move to become the Philippines’ fourth mobile operator after PLDT, Globe and ABS-CBN Mobile;

To know more on the coverage, tap on the link underneath:

https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/philippines-mobile-data-digital-services-are-key-drivers/78617-105.html

Related Links

https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/singapore-embracing-smart-nation-telco-media/78618-105.html

https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/myanmar-4g-investment-new-market-entrants-boost/78616-105.html

Contact:

Ken Research
Ankur Gupta, Head Marketing & Communications
query@kenresearch.com
+91-124-4230204